239 related articles for article (PubMed ID: 11818500)
1. TR surfaces and conformations required to bind nuclear receptor corepressor.
Marimuthu A; Feng W; Tagami T; Nguyen H; Jameson JL; Fletterick RJ; Baxter JD; West BL
Mol Endocrinol; 2002 Feb; 16(2):271-86. PubMed ID: 11818500
[TBL] [Abstract][Full Text] [Related]
2. Identification and characterization of a novel corepressor interaction region in RVR and Rev-erbA alpha.
Burke LJ; Downes M; Laudet V; Muscat GE
Mol Endocrinol; 1998 Feb; 12(2):248-62. PubMed ID: 9482666
[TBL] [Abstract][Full Text] [Related]
3. DNA binding and interaction with the nuclear receptor corepressor of thyroid hormone receptor are required for ligand-independent stimulation of the mouse preprothyrotropin-releasing hormone gene.
Satoh T; Monden T; Ishizuka T; Mitsuhashi T; Yamada M; Mori M
Mol Cell Endocrinol; 1999 Aug; 154(1-2):137-49. PubMed ID: 10509808
[TBL] [Abstract][Full Text] [Related]
4. Molecular determinants required for selective interactions between the thyroid hormone receptor homodimer and the nuclear receptor corepressor N-CoR.
Kim JY; Son YL; Kim JS; Lee YC
J Mol Biol; 2010 Feb; 396(3):747-60. PubMed ID: 20006618
[TBL] [Abstract][Full Text] [Related]
5. The nuclear receptor corepressor (N-CoR) contains three isoleucine motifs (I/LXXII) that serve as receptor interaction domains (IDs).
Webb P; Anderson CM; Valentine C; Nguyen P; Marimuthu A; West BL; Baxter JD; Kushner PJ
Mol Endocrinol; 2000 Dec; 14(12):1976-85. PubMed ID: 11117528
[TBL] [Abstract][Full Text] [Related]
6. The retinoid X receptor binding to the thyroid hormone receptor: relationship with cofactor binding and transcriptional activity.
Tagami T; Yamamoto H; Moriyama K; Sawai K; Usui T; Shimatsu A; Naruse M
J Mol Endocrinol; 2009 May; 42(5):415-28. PubMed ID: 19211732
[TBL] [Abstract][Full Text] [Related]
7. Gene silencing by chicken ovalbumin upstream promoter-transcription factor I (COUP-TFI) is mediated by transcriptional corepressors, nuclear receptor-corepressor (N-CoR) and silencing mediator for retinoic acid receptor and thyroid hormone receptor (SMRT).
Shibata H; Nawaz Z; Tsai SY; O'Malley BW; Tsai MJ
Mol Endocrinol; 1997 Jun; 11(6):714-24. PubMed ID: 9171235
[TBL] [Abstract][Full Text] [Related]
8. Direct interactions between corepressors and coactivators permit the integration of nuclear receptor-mediated repression and activation.
Li X; Kimbrel EA; Kenan DJ; McDonnell DP
Mol Endocrinol; 2002 Jul; 16(7):1482-91. PubMed ID: 12089344
[TBL] [Abstract][Full Text] [Related]
9. The specificity of interactions between nuclear hormone receptors and corepressors is mediated by distinct amino acid sequences within the interacting domains.
Cohen RN; Brzostek S; Kim B; Chorev M; Wondisford FE; Hollenberg AN
Mol Endocrinol; 2001 Jul; 15(7):1049-61. PubMed ID: 11435607
[TBL] [Abstract][Full Text] [Related]
10. Molecular determinants of nuclear receptor-corepressor interaction.
Perissi V; Staszewski LM; McInerney EM; Kurokawa R; Krones A; Rose DW; Lambert MH; Milburn MV; Glass CK; Rosenfeld MG
Genes Dev; 1999 Dec; 13(24):3198-208. PubMed ID: 10617569
[TBL] [Abstract][Full Text] [Related]
11. Structure-function analysis of the Rev-erbA and RVR ligand-binding domains reveals a large hydrophobic surface that mediates corepressor binding and a ligand cavity occupied by side chains.
Renaud JP; Harris JM; Downes M; Burke LJ; Muscat GE
Mol Endocrinol; 2000 May; 14(5):700-17. PubMed ID: 10809233
[TBL] [Abstract][Full Text] [Related]
12. Characterization of receptor interaction and transcriptional repression by the corepressor SMRT.
Li H; Leo C; Schroen DJ; Chen JD
Mol Endocrinol; 1997 Dec; 11(13):2025-37. PubMed ID: 9415406
[TBL] [Abstract][Full Text] [Related]
13. Two receptor interacting domains in the nuclear hormone receptor corepressor RIP13/N-CoR.
Seol W; Mahon MJ; Lee YK; Moore DD
Mol Endocrinol; 1996 Dec; 10(12):1646-55. PubMed ID: 8961273
[TBL] [Abstract][Full Text] [Related]
14. Two separate NCoR (nuclear receptor corepressor) interaction domains mediate corepressor action on thyroid hormone response elements.
Cohen RN; Wondisford FE; Hollenberg AN
Mol Endocrinol; 1998 Oct; 12(10):1567-81. PubMed ID: 9773980
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional silencing by unliganded thyroid hormone receptor beta requires a soluble corepressor that interacts with the ligand-binding domain of the receptor.
Tong GX; Jeyakumar M; Tanen MR; Bagchi MK
Mol Cell Biol; 1996 May; 16(5):1909-20. PubMed ID: 8628257
[TBL] [Abstract][Full Text] [Related]
16. Quantification of ligand-regulated nuclear receptor corepressor and coactivator binding, key interactions determining ligand potency and efficacy for the thyroid hormone receptor.
Jeyakumar M; Webb P; Baxter JD; Scanlan TS; Katzenellenbogen JA
Biochemistry; 2008 Jul; 47(28):7465-76. PubMed ID: 18558711
[TBL] [Abstract][Full Text] [Related]
17. Determination of nuclear receptor corepressor interactions with the thyroid hormone receptor.
Makowski A; Brzostek S; Cohen RN; Hollenberg AN
Mol Endocrinol; 2003 Feb; 17(2):273-86. PubMed ID: 12554754
[TBL] [Abstract][Full Text] [Related]
18. E1A and a nuclear receptor corepressor splice variant (N-CoRI) are thyroid hormone receptor coactivators that bind in the corepressor mode.
Meng X; Webb P; Yang YF; Shuen M; Yousef AF; Baxter JD; Mymryk JS; Walfish PG
Proc Natl Acad Sci U S A; 2005 May; 102(18):6267-72. PubMed ID: 15849266
[TBL] [Abstract][Full Text] [Related]
19. The nuclear receptor corepressor deacetylase activating domain is essential for repression by thyroid hormone receptor.
Ishizuka T; Lazar MA
Mol Endocrinol; 2005 Jun; 19(6):1443-51. PubMed ID: 15695367
[TBL] [Abstract][Full Text] [Related]
20. Recruitment of N-CoR/SMRT-TBLR1 corepressor complex by unliganded thyroid hormone receptor for gene repression during frog development.
Tomita A; Buchholz DR; Shi YB
Mol Cell Biol; 2004 Apr; 24(8):3337-46. PubMed ID: 15060155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
